title: Improving the chance of cure of follicular lymphoma by combining immunotherapy and radioimmunotherapy based on anti-CD20 antibodies?
authors.affiliation: Department of Nuclear Medicine, Lausanne University Hospital, Lausanne; Department of Nuclear Medicine, Geneva University Hospitals, Geneva. Electronic address: franz.buchegger@chuv.ch.
authors.forename: F
authors.initials: F
authors.lastname: Buchegger
authors.affiliation: Department of Biochemistry, University of Lausanne, Lausanne, Switzerland.
authors.forename: J-P
authors.initials: JP
authors.lastname: Mach
authors.affiliation: Department of Medical Oncology, University of Washington Medical Center, Seattle, USA.
authors.forename: O W
authors.initials: OW
authors.lastname: Press
authors.affiliation: Faculty of Medicine, University of Lausanne, Lausanne, Switzerland.
authors.forename: A
authors.initials: A
authors.lastname: Bischof Delaloye
authors.affiliation: Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA.
authors.forename: S M
authors.initials: SM
authors.lastname: Larson
authors.affiliation: Department of Nuclear Medicine, Lausanne University Hospital, Lausanne.
authors.forename: J O
authors.initials: JO
authors.lastname: Prior
authors.affiliation: Clinic Bois-Cerf, Onco-Hematology, Lausanne, Switzerland.
authors.forename: N
authors.initials: N
authors.lastname: Ketterer
mesh_terms: D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000628:therapy*; D008224:Lymphoma, Follicular / Q000532:radiotherapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*